STAT+: A disrupting force, or ‘just another mail order pharmacy’? How Amazon Pharmacy stacks up a year after launching
It was the launch that sent pharmacy stocks into a tailspin.
Within hours of Amazon announcing it was starting Amazon Pharmacy last November, analysts began issuing warnings to investors in would-be rivals including CVS and Walgreens. “Today’s announcement is a net negative” for drug stores, one note from Evercore analysts read. “Retail Pharmacy is trading down big pre-market,” noted another, from Baird. But nearly a year after Amazon Pharmacy’s public debut — and three years after its purchase of specialty pharmacy startup PillPack — it remains unclear how Amazon will carve out its corner in an increasingly crowded market.
Continue to STAT+ to read the full story…
